Combines machine learning with molecular docking to identify effective ALK inhibitors, suggesting new treatment pathways for cancer.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Phan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: